Chinook Therapeutics Inc (KDNY) · page 20 of 36
The text argues that the omission of hematocrit data in the SONAR trial masks a hemodynamic effect that would undermine claims of renal improvement.
Research note · appendix_data · expose_contradiction · balanced density
Slide locked Sign in to view
Slide schematic 3/5
callout 0/1 metric 0/1 paragraph 1/1 source-note 1/1 table 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 5
callout primary paragraph source-note data
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1